New strong buy recommendation by GS as they say this ARIA sales of this blood cancer drug will exceed $500 Million by 2015!! There will be efforts to buy out ARIAD, but if they don't sell we are in for record profits. Stock being manipulated in the interim. Be patient.
Ariad Pharmaceuticals (ARIA)
Ariad launched its first cancer drug (Iclusig, which treats blood cancer) late last year and is on track for more than $50 million in sales this year.
That revenue base could grow as Iclusig begins to be prescribed at earlier stages in cancer development. Iclusig is currently used only when other remedies fail to arrest the cancer's development.
SALES SOULD EXCEED $500 MILLIION BY 2015, ACCORDING TO GOLDMAN SACHS' FORECASTS.
Another cancer drug for Ariad, AP26113, which targets lung cancer, has shown clear promise in early stages of clinical testing.
In the next part of this profile of oncology breakthroughs, we'll look at the novel ways in which scientists are tackling cancer -- as well as at the young biotech firms that may be best positioned to do battle in the next phases of the war on cancer.
Absolutely convinced there is hedge fund collusion going on. Highly illegal, but they seem to get away with it. Perfect example here today. Unlikely one person would have enough shares to cause this drop in PPS. 500 Million in sales for one drug alone. This is strength ,so the hedgies can collectively short into it knowing they will make a few pennies. Pathetic.
Check out the article by The Street Authority, dated May 1st. Contains all the above.
No reason for this PPS to be acting this way OTHER than hedge fund manipulation,...which will no doubt be ongoing from now on. That is, as long as it is ALLOWED by SEC.